Another vaccine candidate, Bharat Biotech's Covaxin, reaches Phase 3 trials. There are now 12 vaccines in this final stage.
In our endeavour to bring out an effective solution to fight the COVID-19 pandemic, we are pleased to announce that Bharat Biotech has received DCGI approval to initiate Phase-3 clinical trials for COVAXIN™️.#BharatBiotech #COVAXIN #clinicaltrials #COVID19 #indiafightscorona pic.twitter.com/prVBnt30Av
— Bharat Biotech (@BharatBiotech) October 23, 2020
Last edited by curl-6 - on 24 October 2020







